Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre
|
October 26, 2011
What's new in decoding breast cancer
Femke de Snoo
Surgical Oncology
|
November 3, 2009
Gene expression profiling: decoding breast cancer
Femke de Snoo, Richard Bender, Annuska Glas, et al.
Breast Cancer Research and Treatment
|
June 13, 2013
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy
Stefan Glück, Femke de Snoo, Justine Peeters, et al.
Medical Oncology (Northwood, London, England)
|
September 5, 2014
Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab chemotherapy
Soley Bayraktar, Melanie Royce, Lisette Stork-Sloots, et al.
Biomarker Insights
|
December 15, 2010
Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer
Sun Tian, Paul Roepman, Laura J Van't Veer, et al.
Breast Cancer Research and Treatment
|
October 2, 2015
Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups
Katharine Yao, Robert Goldschmidt, Mary Turk, et al.
European Journal of Medical Genetics
|
September 15, 2012
Molecular and clinical characterization of patients with a ring chromosome 11
Kerstin B M Hansson, Antoinet C J Gijsbers, Wilma Oostdijk, et al.
Critical Reviews in Oncology/Hematology
|
April 23, 2011
Genomic analysis: toward a new approach in breast cancer management
Sebastiano Cavallaro, Sabrina Paratore, Femke de Snoo, et al.
Breast Care (Basel, Switzerland)
|
July 22, 2015
Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients
Hideo Shimizu, Yoshiya Horimoto, Atsushi Arakawa, et al.
Annals of Surgical Oncology
|
April 28, 2017
Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
Peter Beitsch, Pat Whitworth, Paul Baron, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre
|
October 26, 2011
What's new in decoding breast cancer
Femke de Snoo
Surgical Oncology
|
November 3, 2009
Gene expression profiling: decoding breast cancer
Femke de Snoo, Richard Bender, Annuska Glas, et al.
Breast Cancer Research and Treatment
|
June 13, 2013
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy
Stefan Glück, Femke de Snoo, Justine Peeters, et al.
Medical Oncology (Northwood, London, England)
|
September 5, 2014
Molecular subtyping predicts pathologic tumor response in early-stage breast cancer treated with neoadjuvant docetaxel plus capecitabine with or without trastuzumab chemotherapy
Soley Bayraktar, Melanie Royce, Lisette Stork-Sloots, et al.
Biomarker Insights
|
December 15, 2010
Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer
Sun Tian, Paul Roepman, Laura J Van't Veer, et al.
Breast Cancer Research and Treatment
|
October 2, 2015
Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups
Katharine Yao, Robert Goldschmidt, Mary Turk, et al.
European Journal of Medical Genetics
|
September 15, 2012
Molecular and clinical characterization of patients with a ring chromosome 11
Kerstin B M Hansson, Antoinet C J Gijsbers, Wilma Oostdijk, et al.
Critical Reviews in Oncology/Hematology
|
April 23, 2011
Genomic analysis: toward a new approach in breast cancer management
Sebastiano Cavallaro, Sabrina Paratore, Femke de Snoo, et al.
Breast Care (Basel, Switzerland)
|
July 22, 2015
Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients
Hideo Shimizu, Yoshiya Horimoto, Atsushi Arakawa, et al.
Annals of Surgical Oncology
|
April 28, 2017
Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
Peter Beitsch, Pat Whitworth, Paul Baron, et al.
Page
of 2